KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Asset Utilization Ratio (2016 - 2025)

TherapeuticsMD (TXMD) has disclosed Asset Utilization Ratio for 14 consecutive years, with 0.07 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio rose 80.87% year-over-year to 0.07, compared with a TTM value of 0.07 through Sep 2025, up 80.87%, and an annual FY2024 reading of 0.04, up 120.29% over the prior year.
  • Asset Utilization Ratio was 0.07 for Q3 2025 at TherapeuticsMD, up from 0.07 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 1.33 in Q3 2023 and bottomed at 0.46 in Q3 2022.
  • Average Asset Utilization Ratio over 5 years is 0.16, with a median of 0.05 recorded in 2025.
  • Peak annual rise in Asset Utilization Ratio hit 4494.38% in 2022, while the deepest fall reached 206.18% in 2022.
  • Year by year, Asset Utilization Ratio stood at 0.01 in 2021, then surged by 4494.38% to 0.62 in 2022, then plummeted by 95.19% to 0.03 in 2023, then skyrocketed by 49.69% to 0.04 in 2024, then soared by 61.24% to 0.07 in 2025.
  • Business Quant data shows Asset Utilization Ratio for TXMD at 0.07 in Q3 2025, 0.07 in Q2 2025, and 0.05 in Q1 2025.